S

S2Medical AB (publ)
STO:S2M

Watchlist Manager
S2Medical AB (publ)
STO:S2M
Watchlist
Price: 0.0085 SEK Market Closed
Market Cap: 7.1m SEK
Have any thoughts about
S2Medical AB (publ)?
Write Note

Operating Margin
S2Medical AB (publ)

20.8%
Current
-334%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.8%
=
Operating Profit
2.2m
/
Revenue
10.6m

Operating Margin Across Competitors

Country SE
Market Cap 7.1m SEK
Operating Margin
21%
Country JP
Market Cap 6.8T JPY
Operating Margin
28%
Country CH
Market Cap 37.9B CHF
Operating Margin
13%
Country DK
Market Cap 200.9B DKK
Operating Margin
27%
Country US
Market Cap 16.9B USD
Operating Margin
17%
Country KR
Market Cap 9.9T KRW
Operating Margin
-245%
Country CA
Market Cap 6.9B USD
Operating Margin
4%
Country CN
Market Cap 48.6B CNY
Operating Margin
46%
Country US
Market Cap 6.3B USD
Operating Margin
32%
Country US
Market Cap 6.1B USD
Operating Margin
12%
Country UK
Market Cap 4.8B GBP
Operating Margin
13%
No Stocks Found

S2Medical AB (publ)
Glance View

Market Cap
7.1m SEK
Industry
Health Care

S2Medical AB engages in research and development in biotechnology. The company is headquartered in Linkoping, Ostergotland. The company went IPO on 2018-11-28. The firm focuses on developing products for healing burns and chronic wounds, from debridement and granulation to reepithelialization. The firm's product portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, the Epiprotect product line based on its collagen-mimicking Eiratex material, which includes EPIPROTECT Safestop, a blood-stilling membrane dressing, EPIPROTECT 2117, a synthetic substitute to allografts and xenografts, EPIPROTECT ULCER, dressing for treating ulcers, as well as INSTABIND bandages and Instagraft, a single-use medical device designed to treat chronic wounds with microtransplants from the patient's own skin without creating any new wounds. The firm is also the official distributor of Silverlon antimicrobial dressings for Nordic countries. In addition, it operates the S2Clinic, a wound healing center in Sweden.

S2M Intrinsic Value
0.0322 SEK
Undervaluation 74%
Intrinsic Value
Price
S

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
20.8%
=
Operating Profit
2.2m
/
Revenue
10.6m
What is the Operating Margin of S2Medical AB (publ)?

Based on S2Medical AB (publ)'s most recent financial statements, the company has Operating Margin of 20.8%.